Tecarfarin

替卡法林

Report date: 2025/01/10 10:30:42
NME

Base Information

Drug NameTecarfarin
Drug Alias NametecarfarinumtecarfarinaATI-5000ATI-5923
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin K epOxide reductase complex subunit 1 inhibitors
TargetsVitamin K epOxide reductase complex subunit 1
Therapy Area/IndicationsThrombosisVenous ThromboembolismThromboembolism +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesAryx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLee'S Pharmaceutical LtdLee’S Pharmaceutical Holdings LtdCadrenal Therapeutics Inc +[6] 
Active IndicationsN/A
Inactive IndicationsThrombosisVenous ThromboembolismThromboembolism +[7] 

Other Information

ATC CodeN/A
Related LinksKEGG